Vitamin D: How Much Do You Actually Need?

The RDA is 600 to 800 IU a day, not the 2,000, 5,000, or 10,000 IU doses many bottles push. Here's what the National Institutes of Health actually recommends, how many Americans are really running low, the real difference between D2 and D3, and an honest look at what the immunity and mood claims do — and don't — hold up to.

The Actual RDA, Not the Marketing Number

The Recommended Dietary Allowance (RDA) for vitamin D — the amount the National Academy of Medicine's Food and Nutrition Board says covers the needs of nearly all healthy people — is set by the NIH Office of Dietary Supplements (ODS) at levels most bottle labels never mention next to their own, much larger doses:

*Infant figure is an Adequate Intake (AI), not a full RDA — there isn't enough data to set a formal RDA for that age group.

These numbers assume minimal sun exposure, which is a deliberately conservative assumption — the Food and Nutrition Board built the RDA around dietary and supplemental intake alone, on purpose, so it doesn't rely on people getting adequate unprotected sun. A single 2,000 IU or 5,000 IU softgel, taken daily, isn't dangerous for most healthy adults on its own — but it is several times the RDA, and worth understanding as a deliberate, elevated dose rather than "the normal amount," especially if you're also getting vitamin D from fortified milk, cereal, or a multivitamin.

How Much Is Too Much: The Real Upper Limit

The Tolerable Upper Intake Level (UL) — the highest daily amount ODS considers unlikely to cause harm in the general population — is 4,000 IU (100 mcg) per day for adults and children ages 9 and up, including during pregnancy and lactation. Younger children have lower ULs (3,000 IU for ages 4–8; 2,500 IU for ages 1–3; 1,000–1,500 IU for infants under one year).

Who's Actually Deficient: The Real Numbers

ODS defines the ranges for blood levels of 25-hydroxyvitamin D (25(OH)D), the standard lab test, this way:

The most-cited "40% of Americans are deficient" figure floating around the supplement industry is dated and doesn't match current national data. The most recent CDC/NHANES analysis (2011–2014 cycle) found that, nationally, about 5% of Americans age 1 and up were at risk of deficiency and roughly 18% were at risk of inadequacy — real numbers, but well short of "almost half the country." The picture isn't even across groups, though: risk of deficiency peaked among adults ages 20–39 (about 7.6%) and was substantially higher among non-Hispanic Black Americans specifically (about 17.5% at risk of deficiency and 35.8% at risk of inadequacy) — a documented disparity tied largely to skin-pigmentation's effect on sun-driven vitamin D synthesis, not to diet or supplement use. If you have reason to think you're low — limited sun exposure, darker skin, obesity, malabsorption conditions, or you're simply curious — a blood test is the honest way to know, not a bottle's marketing copy.

D2 vs. D3: A Real, Measurable Difference

Supplements are sold as one of two forms, and they are not identical:

• Vitamin D2 (ergocalciferol) — made by UV-irradiating a plant/fungal sterol (ergosterol). It's the form typically used in the older 50,000 IU prescription capsules doctors sometimes prescribe for a diagnosed severe deficiency.
• Vitamin D3 (cholecalciferol) — made from lanolin (from sheep's wool) or, in newer vegan formulations, from lichen. It's the form your own skin makes from sunlight, and the form used in most over-the-counter supplements.

Multiple systematic reviews and meta-analyses of head-to-head trials have found D3 raises blood 25(OH)D levels more than an equal dose of D2 — one meta-analysis put the difference at roughly 16 nmol/L in D3's favor. That gap is largest with infrequent, large "bolus" dosing (a big once-a-month or once-a-week dose) and narrows considerably — in some analyses, to a difference too small to matter practically — when either form is taken daily. In other words: D3 has a real, replicated edge, but the difference is more meaningful for how a dose is scheduled than it is a reason to worry if a specific multivitamin happens to use D2.

The Immunity Claim: Genuinely Mixed, Not Settled

This is the area where the evidence has actually moved in a documented, honest way — worth walking through rather than flattening into a yes-or-no answer.

In 2017, a large individual-participant-data meta-analysis in The BMJ (Martineau et al., pooling 25 randomized trials and over 11,000 people) found that vitamin D supplementation modestly reduced the odds of having at least one acute respiratory infection — about a 12% relative reduction overall, with the benefit concentrated in people who started out deficient and in those taking daily or weekly doses rather than large infrequent ones. The trial authors' own number-needed-to-treat estimate was 33 — meaning 33 people would need to take vitamin D to prevent one respiratory infection, which is a real but modest effect, not a dramatic one.

That finding got an important update in 2025: a follow-up meta-analysis in The Lancet Diabetes & Endocrinology, incorporating six additional trials including one very large study (over 15,000 participants) that wasn't available in 2017, reran the pooled analysis. The point estimate for the overall effect stayed similar — but the wider dataset pushed the confidence interval to include "no effect," meaning the result is no longer statistically significant at the population level. That's honest science working as intended, not a reason to distrust either paper: a modest, real-looking signal in 2017 didn't hold up as cleanly once more, larger data came in. The most defensible summary right now is that vitamin D's effect on respiratory infections, if any, is small and concentrated in people who are actually deficient to begin with — not a general-population immune booster.

The Mood Claim: A Clean Null Result

The "vitamin D for mood/depression" idea got a rigorous, large-scale test as part of the VITAL trial. VITAL-DEP, published in JAMA in 2020, randomized 18,353 generally healthy older adults (an ancillary study within the larger VITAL cohort) to 2,000 IU/day of vitamin D3 or placebo and tracked depression outcomes for over five years. The result was unambiguous: no difference in new depression diagnoses or depressive-symptom scores between the vitamin D and placebo groups — and that held true even in the subgroup who started the trial with low vitamin D levels. This is one of the better-powered, most direct tests of this specific claim that exists, and it came back negative. It's worth saying plainly: current strong trial evidence does not support taking vitamin D specifically to prevent or treat depression.

The VITAL Trial: Cancer and Heart Disease

The broader VITAL trial (Manson et al., New England Journal of Medicine, 2018–2019) is the largest, longest randomized trial of vitamin D supplementation in generally healthy adults to date — nearly 26,000 U.S. adults, 2,000 IU/day of D3, followed for about 5.3 years. On its two primary endpoints, the result was also a clean null: vitamin D supplementation did not lower the incidence of major cardiovascular events or invasive cancer compared with placebo.

One secondary, exploratory finding is worth naming honestly, with the right caveats attached: in analyses that excluded the first two years of follow-up (to reduce the effect of cancers that were already developing before the trial started), the vitamin D group showed a lower rate of cancer death than placebo. That's a real, published result — but it's a secondary and exploratory analysis, not the trial's primary conclusion, and it hasn't been the trial's headline finding in subsequent reporting or in NIH's own summaries. It's a lead worth future research following up on, not a basis for taking vitamin D as cancer prevention today.

Where Vitamin D Actually Comes From

Sunlight (UVB exposure on skin), fatty fish (salmon, sardines, mackerel), egg yolks, and foods fortified with vitamin D — most U.S. milk, many plant milks, and some breakfast cereals and orange juice — are the main real-world sources. Very few foods contain vitamin D naturally in meaningful amounts, which is the actual reason fortification exists and why supplementation is common, not a marketing invention.

Frequently Asked Questions

Do I need a blood test before taking vitamin D?

Not strictly, for a standard RDA-level dose (600–800 IU) — that's considered safe for essentially all healthy adults without testing first. A blood test becomes worthwhile if you're considering a dose above the RDA, have a risk factor for deficiency (limited sun, darker skin, obesity, malabsorption conditions like celiac or Crohn's disease), or want to confirm a supplement is actually needed rather than guessing.

Is more vitamin D always better for bone health?

No — this is a genuine, evidence-based correction to a common assumption. Some trials have found no added bone-density or fracture benefit from vitamin D doses well above the RDA compared to standard doses, and the UL exists precisely because more isn't simply better past a certain point.

Should I stop taking my multivitamin's vitamin D if it uses D2 instead of D3?

Not necessarily. The D2-vs-D3 gap is most relevant to infrequent, high-dose regimens (like a monthly prescription dose). At typical daily multivitamin doses, the practical difference for most people is small. If you're specifically trying to correct a documented deficiency as quickly as possible, D3 has the stronger evidence behind it.

Sources

• NIH Office of Dietary Supplements, "Vitamin D: Fact Sheet for Health Professionals" (RDA, UL, and 25(OH)D reference ranges)
• Schleicher RL, et al., "National Estimates of Serum Total 25-Hydroxyvitamin D and Metabolite Concentrations Measured by LC-MS-MS in the US Population During 2011–2014," NHANES analysis
• Tripkovic L, et al., "Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis," American Journal of Clinical Nutrition, 2012
• Martineau AR, et al., "Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data," The BMJ, 2017
• Jolliffe DA, et al., "Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of stratified aggregate data," The Lancet Diabetes & Endocrinology, 2025 update
• Okereke OI, et al., "Effect of Long-Term Vitamin D3 Supplementation vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms" (VITAL-DEP), JAMA, 2020
• Manson JE, et al., "Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease" (VITAL trial), New England Journal of Medicine, 2019
• Mayo Clinic, "Vitamin D" and "Vitamin D toxicity: What if you get too much?" patient guidance
• U.S. Pharmacopeia, USP Verified Mark program methodology (quality-supplements.org)